Credit reporting giant Equifax (NYSE:EFX) met Wall Street’s revenue expectations in Q3 2026, with sales up 9.6% year on year to $1.69 billion. On the other hand, next quarter’s revenue guidance of $1.62 billion was less impressive, coming in 3.8% below analysts’ estimates. Its non-GAAP profit of $2.26 per share was 2.8% above analysts’ consensus estimates.
Is now the time to buy EFX? Find out in our full research report (it’s free for active Edge members).
Equifax (EFX) Q3 2026 Highlights:
- Revenue: $1.69 billion vs analyst estimates of $1.69 billion (9.6% year-on-year growth, in line)
- Adjusted EPS: $2.26 vs analyst estimates of $2.20 (2.8% beat)
- Adjusted EBITDA: $560.2 million vs analyst estimates of $553 million (33.1% margin, 1.3% beat)
- Revenue Guidance for Q4 2026 is $1.62 billion at the midpoint, below analyst estimates of $1.68 billion
- Management reiterated its full-year Adjusted EPS guidance of $8.50 at the midpoint
- Operating Margin: 21%, up from 17.1% in the same quarter last year
- Market Capitalization: $20.74 billion
StockStory’s Take
Equifax’s third quarter delivered revenue growth consistent with Wall Street expectations, while non-GAAP profitability exceeded consensus estimates. The market reacted positively, reflecting confidence in the company’s ability to expand margins despite persistent mortgage market weakness. Management credited broad-based performance across its business units, with particular strength in diversified markets and government contract wins. CEO Mark Begor cited improvements in operating leverage and AI-driven productivity, noting, “We delivered above our EBITDA dollar and EPS guidance ranges despite the negative $20 million from the decline in the U.S. mortgage market.”
Looking to the next quarter and beyond, Equifax’s guidance reflects ongoing mortgage market challenges, but management is focused on expanding adoption of new solutions and leveraging AI to drive efficiency. The company expects continued momentum from recent government contract wins and accelerating adoption of alternative credit scoring models. CFO John Gamble highlighted, “Our acceleration of AI and automation benefits is a key focus of our 2027 plans,” while CEO Begor emphasized maintaining the $1 VantageScore price through 2028 to encourage market transition. The company anticipates that technology investments and new product launches will help offset sector-specific headwinds.
Key Insights from Management’s Remarks
Equifax’s management attributed third quarter performance to a mix of AI-powered productivity gains, strong government and diversified market growth, and new product penetration, even as the mortgage market remained a drag. Key updates include:
-
AI-driven cost productivity: Management highlighted rapid deployment of AI tools across operations, technology, and support functions, which enabled margin expansion despite a tough mortgage environment. Equifax doubled its multiyear cost savings target from $75 million to $150 million, citing ongoing momentum in efficiency initiatives.
-
Government contracts and pipeline: The company achieved over $550 million in new and renewed annual contract value with state agencies, mainly in income and employment verification for social service programs. Management described this as a strong underpinning for future growth in the government vertical, with most revenue impact expected in 2027.
-
VantageScore adoption trends: Equifax saw a significant increase in lenders preparing to use the $1 VantageScore model, with over 2,000 mortgage lenders now accessing VantageScore and more than 200 already using it exclusively. Management expects adoption to accelerate as cost savings become more apparent amid industry pressures.
-
Diversified market strength: Growth in consumer lending, talent solutions, and international operations offset mortgage revenue shortfalls. New product launches in background screening (leveraging incarceration and education data) and expansion in Latin America, especially through fintech partnerships, were cited as key drivers.
-
Competitive landscape and regulatory change: Management addressed potential shifts from TriMerge to bi-merge credit reporting requirements, estimating a manageable revenue impact. The company emphasized its differentiated data assets, such as the Twin Indicator and additional data attributes, as competitive advantages in a changing regulatory environment.
Drivers of Future Performance
Equifax’s near-term outlook is shaped by continued mortgage market headwinds, but management expects AI initiatives, new government contracts, and alternative credit scoring adoption to drive performance.
-
Mortgage market pressure: Management expects U.S. mortgage revenue to remain depressed into 2027 if current rate conditions persist, with the bulk of negative impact concentrated in the first eight months of next year. However, management notes a growing pipeline of high-rate mortgages eligible for refinancing if interest rates fall, presenting future upside.
-
AI and automation for margin expansion: Equifax is prioritizing productivity improvements through AI deployment across business units. The company raised its full-year EBITDA margin expansion target to 100 basis points, citing operating leverage and efficiency gains as key levers to offset revenue headwinds.
-
Government and alternative data growth: Signed government contracts will become a larger revenue contributor in 2027, and the company expects increasing adoption of subscription-based verification services. Penetration of products like the Twin Indicator in auto, card, and personal loan markets is also expected to support diversified market growth.
Catalysts in Upcoming Quarters
In the coming quarters, our analysts will watch (1) the pace of VantageScore adoption and whether more large lenders switch to the paid model, (2) the realization of government contract revenue, especially as new state and federal programs come online, and (3) tangible evidence of margin expansion from AI-driven cost savings. We will also monitor regulatory developments affecting credit reporting requirements and the competitive landscape in verification services.
Equifax currently trades at $177.25, up from $158.57 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.